These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An ethanolic extract of Artemisia dracunculus L. regulates gene expression of ubiquitin-proteasome system enzymes in skeletal muscle: potential role in the treatment of sarcopenic obesity. Kirk-Ballard H; Kilroy G; Day BC; Wang ZQ; Ribnicky DM; Cefalu WT; Floyd ZE Nutrition; 2014; 30(7-8 Suppl):S21-5. PubMed ID: 24985101 [TBL] [Abstract][Full Text] [Related]
3. Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I. Lang CH; Huber D; Frost RA Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R328-36. PubMed ID: 16946078 [TBL] [Abstract][Full Text] [Related]
4. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome. Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104 [TBL] [Abstract][Full Text] [Related]
5. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression. Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261 [TBL] [Abstract][Full Text] [Related]
6. Testosterone represses ubiquitin ligases atrogin-1 and Murf-1 expression in an androgen-sensitive rat skeletal muscle in vivo. Pires-Oliveira M; Maragno AL; Parreiras-e-Silva LT; Chiavegatti T; Gomes MD; Godinho RO J Appl Physiol (1985); 2010 Feb; 108(2):266-73. PubMed ID: 19926828 [TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1. Biedasek K; Andres J; Mai K; Adams S; Spuler S; Fielitz J; Spranger J PLoS One; 2011 Jan; 6(1):e16674. PubMed ID: 21304964 [TBL] [Abstract][Full Text] [Related]
8. Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior muscle. Clavel S; Coldefy AS; Kurkdjian E; Salles J; Margaritis I; Derijard B Mech Ageing Dev; 2006 Oct; 127(10):794-801. PubMed ID: 16949134 [TBL] [Abstract][Full Text] [Related]
9. The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass. Rom O; Reznick AZ Free Radic Biol Med; 2016 Sep; 98():218-230. PubMed ID: 26738803 [TBL] [Abstract][Full Text] [Related]
10. An extract of Artemisia dracunculus L. inhibits ubiquitin-proteasome activity and preserves skeletal muscle mass in a murine model of diabetes. Kirk-Ballard H; Wang ZQ; Acharya P; Zhang XH; Yu Y; Kilroy G; Ribnicky D; Cefalu WT; Floyd ZE PLoS One; 2013; 8(2):e57112. PubMed ID: 23437325 [TBL] [Abstract][Full Text] [Related]
11. MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD. Natanek SA; Riddoch-Contreras J; Marsh GS; Hopkinson NS; Moxham J; Man WD; Kemp PR; Polkey MI COPD; 2013 Oct; 10(5):618-24. PubMed ID: 23844868 [TBL] [Abstract][Full Text] [Related]
12. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091 [TBL] [Abstract][Full Text] [Related]
13. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study. Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630 [TBL] [Abstract][Full Text] [Related]
14. Blockade of forkhead box protein O1 signaling alleviates primary sclerosing cholangitis-induced sarcopenia in mice model. Kim DH; Kim J; Park J; Kim TH; Han YH Life Sci; 2024 Nov; 356():123042. PubMed ID: 39233198 [TBL] [Abstract][Full Text] [Related]
15. Sarcopenia in a mice model of chronic liver disease: role of the ubiquitin-proteasome system and oxidative stress. Campos F; Abrigo J; Aguirre F; Garcés B; Arrese M; Karpen S; Cabrera D; Andía ME; Simon F; Cabello-Verrugio C Pflugers Arch; 2018 Oct; 470(10):1503-1519. PubMed ID: 29926227 [TBL] [Abstract][Full Text] [Related]
16. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. Edström E; Altun M; Hägglund M; Ulfhake B J Gerontol A Biol Sci Med Sci; 2006 Jul; 61(7):663-74. PubMed ID: 16870627 [TBL] [Abstract][Full Text] [Related]
17. Protective Effect of Angiotensin 1-7 on Sarcopenia Induced by Chronic Liver Disease in Mice. Aguirre F; Abrigo J; Gonzalez F; Gonzalez A; Simon F; Cabello-Verrugio C Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485991 [TBL] [Abstract][Full Text] [Related]
18. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes. Castillero E; Alamdari N; Lecker SH; Hasselgren PO Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle. Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877 [TBL] [Abstract][Full Text] [Related]
20. Regulation of ubiquitin proteasome pathway molecular markers in response to endurance and resistance exercise and training. Stefanetti RJ; Lamon S; Wallace M; Vendelbo MH; Russell AP; Vissing K Pflugers Arch; 2015 Jul; 467(7):1523-1537. PubMed ID: 25104573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]